New treatment boosts daily skills and social interactions in Down syndrome

EUREKALERT

A groundbreaking clinical trial has shown that a new drug safely improves cognitive function, daily skills, and social interactions for people with Down syndrome, a huge step towards more independence and improved quality of life for affected individuals.